How to Define Pathogenicity, Health, and Disease? - Wikidata - wikimedia - TriplyDB

How to Define Pathogenicity, Health, and Disease?

How to Define Pathogenicity, Health, and Disease?

http://www.wikidata.org/entity/Q36197950

about

Predicting Severity of Disease-Causing Variants.PON-P and PON-P2 predictor performance in CAGI challenges: Lessons learned.Large differences in proportions of harmful and benign amino acid substitutions between proteins and diseases

P2860

Q36245217-314AAA03-5F55-4D15-9E43-9128AA58569C Q38754630-3F888764-17E9-4D69-AF31-D04173967663 Q58531670-48B3661D-288A-4B02-B39E-5A3624B18464

P2860

How to Define Pathogenicity, Health, and Disease?

http://www.wikidata.org/entity/Q36197950

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

How to Define Pathogenicity, Health, and Disease?

@ast

How to Define Pathogenicity, Health, and Disease?

@en

type

label

How to Define Pathogenicity, Health, and Disease?

@ast

How to Define Pathogenicity, Health, and Disease?

@en

prefLabel

How to Define Pathogenicity, Health, and Disease?

@ast

How to Define Pathogenicity, Health, and Disease?

@en

P1433

Q36197950-F1947A03-0763-4F00-9CBC-085CA7B9302D

P1476

Q36197950-C0FCA7BE-5B58-42E6-9262-5127215E31FF

P2093

Q36197950-DB3F136C-449B-4273-9E5A-016353005131

P2860

Q36197950-0212FFC1-1709-4A95-B1C0-83C8FBA173E3

Q36197950-02139532-0D5B-4DAA-9B45-CA7FE0EC5937

Q36197950-02F9DF10-7EEB-4365-ADA5-AEBA05D2D345

Q36197950-042BF3F2-B1FF-4088-846B-D2A5667EB201

Q36197950-0C025C8C-82C2-4AC4-B3F0-F1492EAE6D98

Q36197950-0C352F47-CFCD-4C96-954D-208D54718C23

Q36197950-0D65A478-2907-435A-A422-9A45AC617DC9

Q36197950-1704799A-BFE4-4503-B0DE-64ED6F38126E

Q36197950-1D967C47-52B4-4BCD-A4BE-F36B4B8FE146

Q36197950-25636913-6C5B-4F05-B99A-FDAFD1FFBD24

P304

Q36197950-6495728F-FFF7-4CFF-929E-DACB44876668

P31

Q36197950-16E1078B-B73B-49F3-9351-C8E8803CB054

P356

Q36197950-E64D648C-B286-4F59-BC96-5E0483D4DB89

P433

Q36197950-24899C6E-E590-431B-B8F3-33D750FDB990

P478

Q36197950-0EC36F75-1C90-48F1-9675-221DCF4CB3B3

P50

Q36197950-A4CD622C-0DB6-4094-96AE-BD4B2EABEB1B

P577

Q36197950-2A6B34B3-3D25-4C4A-830C-31D92DA80F9F

P698

Q36197950-39EE93F8-A6EE-4213-B370-DFE1D9B08003

P356

P1433

P1476

How to Define Pathogenicity, Health, and Disease?

@en

P2093

Mauno Vihinen

http://www.w3.org/2001/XMLSchema#string

P2860

Genotype to phenotype: a complex problem

Defining comorbidity: implications for understanding health and health services

SAPS 3--From evaluation of the patient to evaluation of the intensive care unit. Part 1: Objectives, methods and cohort description

PON-P2: prediction method for fast and reliable identification of harmful variants

Variation Ontology for annotation of variation effects and mechanisms

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Actionable exomic incidental findings in 6503 participants: challenges of variant classification

A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data.

The MDS Mortality Risk Index: The evolution of a method for predicting 6-month mortality in nursing home residents.

Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force.

P304

129-136

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HUMU.23144

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-11-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27862583

http://www.w3.org/2001/XMLSchema#string